Morgan Stanley on Johnson & Johnson (JNJ): We view this development as an incremental positive for the stock
Tweet Send to a Friend
Morgan Stanley analyst Terrance Flynn reiterated an Equalweight rating and $180.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
